HomeTOP STORIESOcular gains as Wet AMD trial for lead asset reaches enrollment target Ocular gains as Wet AMD trial for lead asset reaches enrollment target By rogerjudd May 28, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleHere’s why ETF investors are paying attention to NVDA’s earningsNext articleFederal Reserve officials say U.S. economic outlook faces ‘usually elevated’ uncertainty: FOMC minutes latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
